Application of lisinopril in the complex correction of the vessel wall antiaggregational activity in patients with arterial hypertension and metabolic syndrome who suffered from occlusion of the eye vessels

The aim of this work is to investigate the possibilities of correction of a vessel wall antiaggregational activity in patients with arterial hypertension and metabolic syndrome, who suffered from occlusion of eye vessels by using complex therapy including lisinopril, Pioglitason and non-medic correction. It's found out that in such patients this complex is able to normalize the vessel wall antiaggregational activity during 4 months of therapy. The achieved results were observed even during not full non-medical correction in conditions of adverse ecology.

vessel wall, arterial hypertension, metabolic syndrome, occlusion of eye vessels in the anamnesis